Why Should You Put Clearwater Analytics Holdings Inc (NYSE: CWAN) On Your Portfolio?

Currently, there are 270.74M common shares owned by the public and among those 238.19M shares have been available to trade.

The company’s stock has a 5-day price change of -0.90% and -4.42% over the past three months. CWAN shares are trading 18.80% year to date (YTD), with the 12-month market performance down to -19.88% lower. It has a 12-month low price of $18.75 and touched a high of $35.71 over the same period. CWAN has an average intraday trading volume of 3.76 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 0.13%, -2.96%, and -15.98% respectively.

Institutional ownership of Clearwater Analytics Holdings Inc (NYSE: CWAN) shares accounts for 83.35% of the company’s 270.74M shares outstanding.

It has a market capitalization of $6.25B and a beta (3y monthly) value of 0.73. The stock’s trailing 12-month PE ratio is 13.24, while the earnings-per-share (ttm) stands at $1.67. The company has a PEG of 0.55 and a Quick Ratio of 5.03 with the debt-to-equity ratio at 0.06. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.07% over the week and 3.07% over the month.

Earnings per share for the fiscal year are expected to increase by 14.50%, and 24.30% over the next financial year. EPS should shrink at an annualized rate of 24.07% over the next five years, compared to 119.42% over the past 5-year period.

Looking at the support for the CWAN, a number of firms have released research notes about the stock. Piper Sandler stated their Overweight rating for the stock in a research note on June 24, 2025, with the firm’s price target at $27. Goldman coverage for the Clearwater Analytics Holdings Inc (CWAN) stock in a research note released on May 19, 2025 offered a Neutral rating with a price target of $26. JP Morgan was of a view on April 25, 2025 that the stock is Overweight, while Piper Sandler gave the stock Overweight rating on February 20, 2025, issuing a price target of $28- $36. Morgan Stanley on their part issued Overweight rating on January 17, 2025.

Related Posts

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.